These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 1976080)

  • 1. Unsubstituted amides: new class of potent inhibitors of human microsomal epoxide hydrolase.
    Kerr BM; Levy RH
    Drug Metab Dispos; 1990; 18(4):540-2. PubMed ID: 1976080
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation.
    Kerr BM; Rettie AE; Eddy AC; Loiseau P; Guyot M; Wilensky AJ; Levy RH
    Clin Pharmacol Ther; 1989 Jul; 46(1):82-93. PubMed ID: 2501059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid.
    Spiegelstein O; Kroetz DL; Levy RH; Yagen B; Hurst SI; Levi M; Haj-Yehia A; Bialer M
    Pharm Res; 2000 Feb; 17(2):216-21. PubMed ID: 10751038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae. Study of the valpromide-carbamazepine epoxide interaction.
    Eugster HP; Sengstag C; Hinnen A; Meyer UA; Würgler FE
    Biochem Pharmacol; 1991 Sep; 42(7):1367-72. PubMed ID: 1930259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid-carbamazepine interaction: is valproic acid a selective inhibitor of epoxide hydrolase?
    Svinarov DA; Pippenger CE
    Ther Drug Monit; 1995 Jun; 17(3):217-20. PubMed ID: 7624916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine-valnoctamide interaction in epileptic patients: in vitro/in vivo correlation.
    Pisani F; Haj-Yehia A; Fazio A; Artesi C; Oteri G; Perucca E; Kroetz DL; Levy RH; Bialer M
    Epilepsia; 1993; 34(5):954-9. PubMed ID: 8104783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of carbamazepine and its epoxide metabolite in human and rat liver in vitro.
    Tybring G; von Bahr C; Bertilsson L; Collste H; Glaumann H; Solbrand M
    Drug Metab Dispos; 1981; 9(6):561-4. PubMed ID: 6120817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-reactive metabolites of carbamazepine in mouse liver microsomes.
    Lillibridge JH; Amore BM; Slattery JT; Kalhorn TF; Nelson SD; Finnell RH; Bennett GD
    Drug Metab Dispos; 1996 May; 24(5):509-14. PubMed ID: 8723729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saccharomyces cerevisiae: an alternative source for human microsomal liver enzymes and its use in drug interaction studies.
    Eugster HP; Sengstag C
    Toxicology; 1993 Oct; 82(1-3):61-73. PubMed ID: 8236282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro correlation of microsomal epoxide hydrolase inhibition by progabide.
    Kroetz DL; Loiseau P; Guyot M; Levy RH
    Clin Pharmacol Ther; 1993 Nov; 54(5):485-97. PubMed ID: 8222491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valpromide inhibits human epoxide hydrolase.
    Pacifici GM; Franchi M; Bencini C; Rane A
    Br J Clin Pharmacol; 1986 Sep; 22(3):269-74. PubMed ID: 3094569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of liver microsomal epoxide hydrase by cyproheptadine epoxide.
    Pachecka J; Salmona M; Belvedere G; Cantoni L; Mussini E; Garattini S
    Experientia; 1977 Apr; 33(4):484-5. PubMed ID: 862740
    [No Abstract]   [Full Text] [Related]  

  • 13. Human liver microsomal epoxide hydrolase. Correlation of immunochemical quantitation with catalytic activity.
    Thomas PE; Ryan DE; von Bahr C; Glaumann H; Levin W
    Mol Pharmacol; 1982 Jul; 22(1):190-5. PubMed ID: 6811857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-urea functionality as the primary pharmacophore in soluble epoxide hydrolase inhibitors.
    Anandan SK; Do ZN; Webb HK; Patel DV; Gless RD
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1066-70. PubMed ID: 19168352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors.
    Shen HC; Ding FX; Deng Q; Xu S; Tong X; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Roy S; Zhang B; Tata JR; Berger JP; Colletti SL
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5716-21. PubMed ID: 19700315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of metabolically stable inhibitors of Mammalian microsomal epoxide hydrolase.
    Morisseau C; Newman JW; Wheelock CE; Hill Iii T; Morin D; Buckpitt AR; Hammock BD
    Chem Res Toxicol; 2008 Apr; 21(4):951-7. PubMed ID: 18363382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of drug-drug interactions with carbamazepine-10,11-epoxide using a new in vitro assay for epoxide hydrolase inhibition.
    Rosa M; Bonnaillie P; Chanteux H
    Xenobiotica; 2016 Dec; 46(12):1076-1084. PubMed ID: 26936324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valpromide but not sodium hydrogen divalproate inhibits epoxide hydrolase in human liver.
    Pacifici GM; Rane A
    Pharmacol Toxicol; 1987 Mar; 60(3):237-8. PubMed ID: 3108874
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of valproic acid and some analogues with microsomal epoxide hydrolase.
    Robbins DK; Wedlund PJ; Elsberg S; Oesch F; Thomas H
    Biochem Pharmacol; 1992 Feb; 43(4):775-83. PubMed ID: 1540232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of epoxide hydrolase by anticonvulsants and risk of teratogenicity.
    Kerr BM; Levy RH
    Lancet; 1989 Mar; 1(8638):610-1. PubMed ID: 2564126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.